Skip to main content
SpringerLink
Log in
Book cover

Liver Cancer pp 325–340Cite as

Therapy of Metastatic Carcinoid Tumor and the Carcinoid Syndrome

  • Chapter

  • 72 Accesses

Part of the book series: Developments in Oncology ((DION,volume 30))

Abstract

The carcinoid tumor, an uncommon but not rare neoplasm, offers an exciting and multifaceted challenge for oncologic management—a challenge that demands informed multidisciplinary interaction of surgical and medical oncologists as well as the diagnostic radiologist and laboratory scientist.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Riddle PJ, Font RL, Zimmerman LE. Carcinoid tumors of the eye and orbit. Human Path 13:459–469, 1982.

    Article  CAS  Google Scholar 

  2. Davis Z, Moertel CG, McIlrath DC. The malignant carcinoid syndrome. Surg Gynec Obstet 137:637–644, 1973.

    PubMed  CAS  Google Scholar 

  3. Moertel CG, Hanley JA. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Clin Cancer Trials 2:327–334, 1979.

    CAS  Google Scholar 

  4. Martin JK, Moertel CG, Adson MA, Schutt AJ. Surgical treatment of functioning metastatic carcinoid tumors. Arch Surg 118:537–542, 1983.

    PubMed  Google Scholar 

  5. Strickman NE, Rossi PA, Massum Kharis GA, Hall RJ. Carcinoid heart disease. Curr Prob Cardiol 6:1–41, 1982.

    Article  CAS  Google Scholar 

  6. Moertel CG, Hanley JA, Johnson LA. Streptozotocin alone compared with streptozotocin plus fluorouracil in the treatment of advanced islet cell carcinoma. New Eng J Med 303:1189–1195, 1980.

    Article  PubMed  CAS  Google Scholar 

  7. Feldman JA. Serotonin metabolism in patients with carcinoid tumors. Gastroenterol 75:1109–1114, 1978.

    CAS  Google Scholar 

  8. Engstrom P, Lavin P, Folsch E, Moertel CG. Streptozotocin plus fluorouracil vs. adriamycin for metastatic carcinoid tumor. Proc Am Assoc Cancer Res 24:139, 1983.

    Google Scholar 

  9. Legha SS, Valdivieso M, Nelson RS, Benjamin RS, Bodey GP. Chemotherapy for metastatic carcinoid tumors. Cancer Treat Rep 61:1699–1703, 1981.

    Google Scholar 

  10. Rochlin DB, Smart CR, Silva A. Chemotherapy of malignancies of the gastrointestinal tract. Am J Surg 109:43–46, 1965.

    Article  PubMed  CAS  Google Scholar 

  11. VanHazel GA, Rubin J, Moertel CG. Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine. Cancer Treat Rep 67:577–579, 1983.

    Google Scholar 

  12. Kessinger A, Foley FJ, Lemon HJ. Use of DTIC (dacarbazine) in the malignant carcinoid syndrome. Cancer Treat Rep 61:101–102, 1977.

    PubMed  CAS  Google Scholar 

  13. Dolinger M, Golbey R. Actinomycin D in the treatment of the carcinoid tumors. Clin Res 15:335, 1967.

    Google Scholar 

  14. Mengel CE, Shaffer RD. The carcinoid syndrome. In Cancer Medicine. Holland JF, Frei E (eds). Philadelphia: Lea & Febiger, 1973, pp. 1584–1593.

    Google Scholar 

  15. Melia WM, Nummerley HB, Johnson PJ, Williams R. Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome. Br J Cancer 46:331–339, 1982.

    Article  PubMed  CAS  Google Scholar 

  16. Stolinsky DC, Sadoff L, Braunwald J, Bateman JR. Streptozotocin in the treatment of cancer. Phase II study. Cancer 30:61–67, 1972.

    Article  Google Scholar 

  17. Feldman JM, Quickel RE (Jr), Muracek RL, Lebovitz HE. Streptozotocin treatment of metastatic carcinoid tumors. South Med J 65:1325–1327, 1972.

    Article  PubMed  CAS  Google Scholar 

  18. Schein PS, O’Connell MJ, Blom J, Hubbard S, McGrath IT, Bergevin P, Wiernik PH, Ziegler JL, DeVita VT. Clinical antitumor activity and toxicity of streptozotocin. Cancer 34:993–1000, 1974.

    Article  PubMed  CAS  Google Scholar 

  19. Stathopoulos GP, Karvoantzis GG, Yiotis J. Tamoxifen in carcinoid syndrome. N Eng J Med 305:52, 1981.

    CAS  Google Scholar 

  20. Myers CF, Ershler WB, Tannenbaum MA, Barth R. Tamoxifen and carcinoid tumor. Ann Int Med 96:383, 1982.

    PubMed  CAS  Google Scholar 

  21. Harris AL, Smith IE. Regression of carcinoid tumour with cyproheptadine. Br Med J 285:475, 1982.

    Article  CAS  Google Scholar 

  22. Oberg K, Funa K, Alm G. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. New Engl J Med 309:129–132, 1983.

    Article  PubMed  CAS  Google Scholar 

  23. Moertel CG, O’Connell MJ, Reitemeier RJ, Rubin J. An evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Treat Rep 68:665–667, 1984.

    PubMed  CAS  Google Scholar 

  24. Ajani JA, Legha SS, Karlin JA, Hill CS. Combination chemotherapy of metastatic carcinoid tumors with 5-FU, adriamycin, and Cytoxan and 5-FU, adriamycin, mitomycin, and methyl CCNU. Proc Am Soc Clin Oncol 2:124, 1983 (Abstract).

    Google Scholar 

  25. Bukowski RM, Stephens R, Oishi N, Petersen R, Chen T. Phase II trial of 5-FU, adriamycin, cyclophosphamide, and streptozotocin (FAC-S) in metastatic carcinoid. Proc Am Soc Clin Oncol 2:130, 1983 (Abstract).

    Google Scholar 

  26. Kelsen DP, Cheng E, Kemeny N, Magill GB, Yagoda A. Streptozotocin and adriamycin in the treatment of APUD tumors. Proc Am Assoc Cancer Res 23:433, 1982 (Abstract).

    Google Scholar 

  27. Legha SS et al. Chemotherapy for metastatic carcinoid tumors. Cancer Treat Rep 61:1699–1703, 1981.

    Google Scholar 

  28. Bean WB, Olch D, Weinberg HB. The syndrome of carcinoid and acquired valve lesions of the right side of the heart. Circulation 12:1–6, 1955.

    PubMed  CAS  Google Scholar 

  29. Sandler M. The role of 5-hydroxyindoles in the carcinoid syndrome. Advance Pharmacol 6:127–142, 1968.

    Article  CAS  Google Scholar 

  30. Metz SA, Haller JR, Porte D, Robertson RP. Suppression of plasma catecholamines and flushing by Clonidine in man. J Clin Endocrinol Metab 46:83–90, 1978.

    Article  PubMed  CAS  Google Scholar 

  31. Arnold AC, Leichter SB. Use of novel pharmacologic agents in carcinoid syndrome. Milit Med 142:949–950, 1977.

    CAS  Google Scholar 

  32. Levine RJ, Sjoerdsma A. Pressor amines and the carcinoid flush. Ann Int Med 58:818–828, 1963.

    PubMed  CAS  Google Scholar 

  33. Ludwig GD, Cushard W, Bartuska D, Franco R, Chaykin L. Effects of beta-adrenergic blockade in the carcinoid syndrome. Ann Int Med 68:1188, 1968.

    Google Scholar 

  34. Sjoerdsma A, Weissbach H, Terry LL, Udenfriend S. Further observations on patients with malignant carcinoid. Am J Med 23:5–15, 1957.

    Article  PubMed  CAS  Google Scholar 

  35. Sjoerdsma A, Oates JA, Zaltzman P, Uderfriend S. Serotonin synthesis in carcinoid patients; its inhibition by alpha-methyl-DOPA, with measurement of associated increases in urinary 5-hydroxytrytophan. New Engl J Med 263-585–588, 1960.

    Article  PubMed  CAS  Google Scholar 

  36. Costello C. Carcinoid tumor metastases. Am J Surg 130:756–759, 1975.

    Article  PubMed  CAS  Google Scholar 

  37. Sjoerdsma A, Lovenberg W, Engelman K. Serotonin now: clinical implications of inhibiting its synthesis with parachlorophenylalanine. Ann Int Med 73:607–629, 1970.

    CAS  Google Scholar 

  38. Vroom FQ, Brown RE, Demsey H, Hill SR. Studies on several possible antiserotonin compounds in a patient with the functioning carcinoid syndrome. Ann Int Med 56:941–945, 1962.

    PubMed  CAS  Google Scholar 

  39. Melmon KL, Sjoerdsma A, Oates JA, Laster L. Treatment of malabsorption and diarrhea of the carcinoid syndrome with methysergide. Gastroenterol 48:18–24, 1965.

    CAS  Google Scholar 

  40. Wilkin JE, Rountree CB. Blockade of carcinoid flush with Cimetidine and Clonidine. Arch Dermatol 118:109–111, 1982.

    Article  PubMed  CAS  Google Scholar 

  41. Sjoerdsma A, Melmon KL. Severe flushing reactions responsive to steroids in patients with bronchial carcinoid. Lancet 2:791–792, 1964.

    Article  PubMed  CAS  Google Scholar 

  42. Stahl SM, Levin B. Serotonin depletion by fenfluramine in the carcinoid syndrome. New Engl J Med 306:429, 1982.

    PubMed  CAS  Google Scholar 

  43. Frohlic JC, Bloomgarden ZI, Oates JA, McGuigan JE, Robinowitz, D. The carcinoid flush: provocation by pentagastrin and inhibition by somatostatin. N Engl J Med 299:1055–1057, 1978.

    Article  Google Scholar 

  44. Krols LK, Moertel CG, Schutt AJ, O’Connell MJ. A somatostatin analogue in therapy of malignant carcinoid syndrome. Proc Am Soc Clin Oncol 4:89, 1985 (Abstract).

    Google Scholar 

Download references

Authors
  1. Charles G. Moertel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rita and Stanley H. Kaplan Cancer Center, New York University Medical Center, 550 First Avenue, New York, NY, 10016, USA

    Joseph C. Bottino M.D.  & Franco M. Muggia M.D.  & 

  2. Clinical Oncology Program, University of California,Irvine Medical Center, Orange, CA, 92668, USA

    Richard W. Opfell M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishing, Boston/Dordrecht/Lancaster

About this chapter

Cite this chapter

Moertel, C.G. (1985). Therapy of Metastatic Carcinoid Tumor and the Carcinoid Syndrome. In: Bottino, J.C., Opfell, R.W., Muggia, F.M. (eds) Liver Cancer. Developments in Oncology, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2593-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2593-2_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9625-6

  • Online ISBN: 978-1-4613-2593-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation